FR3146899B1 - Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange - Google Patents

Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange

Info

Publication number
FR3146899B1
FR3146899B1 FR2302635A FR2302635A FR3146899B1 FR 3146899 B1 FR3146899 B1 FR 3146899B1 FR 2302635 A FR2302635 A FR 2302635A FR 2302635 A FR2302635 A FR 2302635A FR 3146899 B1 FR3146899 B1 FR 3146899B1
Authority
FR
France
Prior art keywords
cross
linked polysaccharide
mixture
preparing
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2302635A
Other languages
English (en)
Other versions
FR3146899A1 (fr
Inventor
Romain Brusini
Camille Vantou
Jimmy Faivre
François Bourdon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teoxane SA
Original Assignee
Teoxane SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teoxane SA filed Critical Teoxane SA
Priority to FR2302635A priority Critical patent/FR3146899B1/fr
Priority to CN202480029566.9A priority patent/CN121152616A/zh
Priority to PCT/EP2024/057635 priority patent/WO2024194420A1/fr
Priority to AU2024240156A priority patent/AU2024240156A1/en
Priority to EP24712108.0A priority patent/EP4683613A1/fr
Publication of FR3146899A1 publication Critical patent/FR3146899A1/fr
Application granted granted Critical
Publication of FR3146899B1 publication Critical patent/FR3146899B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La divulgation concerne un procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, un polysaccharide non réticulé, ou leur mélange, le procédé comprenant les étapes suivantes : (1) préparation d’un hydrogel comprenant un polysaccharide réticulé, un polysaccharide non réticulé ou leur mélange et comprenant en outre au moins 1 mM d’ions citrates ; et (2) stérilisation, de préférence à la chaleur, de l’hydrogel comprenant au moins 1 mM d’ions citrates pour obtenir un hydrogel stérile comprenant un polysaccharide réticulé, un polysaccharide non réticulé ou leur mélange.
FR2302635A 2023-03-21 2023-03-21 Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange Active FR3146899B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR2302635A FR3146899B1 (fr) 2023-03-21 2023-03-21 Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange
CN202480029566.9A CN121152616A (zh) 2023-03-21 2024-03-21 用于制备包含交联或非交联多糖或其混合物的无菌水凝胶的方法
PCT/EP2024/057635 WO2024194420A1 (fr) 2023-03-21 2024-03-21 Procédé de préparation d'un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange
AU2024240156A AU2024240156A1 (en) 2023-03-21 2024-03-21 Method for preparing a sterile hydrogel comprising a cross-linked or non-crosslinked polysaccharide or a mixture thereof
EP24712108.0A EP4683613A1 (fr) 2023-03-21 2024-03-21 Procédé de préparation d'un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2302635 2023-03-21
FR2302635A FR3146899B1 (fr) 2023-03-21 2023-03-21 Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange

Publications (2)

Publication Number Publication Date
FR3146899A1 FR3146899A1 (fr) 2024-09-27
FR3146899B1 true FR3146899B1 (fr) 2026-03-20

Family

ID=86942831

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2302635A Active FR3146899B1 (fr) 2023-03-21 2023-03-21 Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange

Country Status (5)

Country Link
EP (1) EP4683613A1 (fr)
CN (1) CN121152616A (fr)
AU (1) AU2024240156A1 (fr)
FR (1) FR3146899B1 (fr)
WO (1) WO2024194420A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945293B1 (fr) 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
FR2968305B1 (fr) 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
US20200054786A1 (en) * 2016-10-13 2020-02-20 Allergan, Inc. Coacervate hyaluronan hydrogels for dermal filler applications
EP3538066B1 (fr) * 2016-11-11 2021-12-29 Anteis SA Compositions de comblement dermique comprenant de l'acide hyaluronique réticulé avec l'acide citrique. procédé de fabrication de celui-ci et utilisation de celui-ci

Also Published As

Publication number Publication date
EP4683613A1 (fr) 2026-01-28
WO2024194420A1 (fr) 2024-09-26
CN121152616A (zh) 2025-12-16
AU2024240156A1 (en) 2025-10-09
FR3146899A1 (fr) 2024-09-27

Similar Documents

Publication Publication Date Title
US6228900B1 (en) Crosslinking of polyethylene for low wear using radiation and thermal treatments
US8008365B2 (en) Crosslinking of polyethylene for low wear using radiation and thermal treatments
WO2012061497A1 (fr) Matériaux polymères modifiés et procédés de modification de matériaux polymères
FR3146899B1 (fr) Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange
EP0230945B1 (fr) Substance liant la thrombine et son procédé de préparation
CA2032991A1 (fr) Membrane semi-permeable asymetrique pour le traitement des liquides biologiques
JP2009504283A (ja) 超高分子量ポリエチレン物品および超高分子量ポリエチレン物品を形成する方法
JPH05294999A (ja) 細胞障害性リンパ球成熟因子およびそれに対するモノクローナル抗体
FR2433360A1 (fr) Dispositif sterile servant a recueillir et a separer le sang
EP3922632A4 (fr) Agent de dégradation induisant la dégradation d'une protéine eed cible, son procédé de préparation, et composition pharmaceutique pour la prévention ou le traitement de maladies associées à eed, ezh2 ou prc2, comprenant celui-ci en tant que principe actif
EP2343370A1 (fr) Enzyme de type thrombine d'agkistrodon acutus
DE69101634D1 (de) Rekombinant hergestellte blutfaktoren, verfahren zur exprimierung besagter blutfaktoren sowie in besagtem prozess verwendeter rekombinanter vaccina-virus.
MA66371B1 (fr) Dérivés de s-alaninate substitués
Jiang et al. Batroxobin can improve the efficacy of combination therapy for profound sudden sensorineural hearing loss greater than but not less than 100 dB HL
EP4414391A4 (fr) Agent de modification, polymère à base de diène conjugué modifié le comprenant, et procédé de préparation de polymère
AT397390B (de) Verfahren zur spaltung von proteinen
EP4331593A4 (fr) Composition pharmaceutique pour la prévention ou le traitement de la maladie de parkinson, et son procédé de préparation
AU8131098A (en) Agents comprising Midkine or its inhibitor as active ingredient
RU2004103626A (ru) Материалы и способы, относящиеся к аутологичным т-клеточным вакцинам
JP6292815B2 (ja) 抗酸化性人工補綴部材
EP4233862A4 (fr) Médicament pour soulager ou éliminer le syndrome d'abstinence prolongée aux opiacés et son procédé de préparation
MA26648A1 (fr) Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation.
KR20070113876A (ko) 혈장성분을 함유하는 창상 치료용 약학 조성물
EP4079806A4 (fr) Polymère à base de diène conjugué modifié étendu à l'huile, procédé de préparation associé, et composition de caoutchouc le comprenant
RU2093588C1 (ru) Способ вакуумной термической обработки мелкоразмерного инструмента из быстрорежущей стали

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20240927

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4